BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34080377)

  • 1. [Pre-cancerous lung lesions and lung cancer screening].
    Duquenne JB; Paulus A; Sibille A; Corhay JL; Louis R; Duysinx B
    Rev Med Liege; 2021 May; 76(5-6):440-445. PubMed ID: 34080377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
    Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
    Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.
    van den Bergh KA; Essink-Bot ML; Borsboom GJ; Scholten ET; van Klaveren RJ; de Koning HJ
    Eur Respir J; 2011 Jul; 38(1):154-61. PubMed ID: 21148229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer screening: Nelson study is finally published].
    Birsen G; Revel MP; Wislez M
    Bull Cancer; 2020 Feb; 107(2):143-144. PubMed ID: 32113512
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for lung cancer: time for large-scale screening by chest computed tomography.
    Shlomi D; Ben-Avi R; Balmor GR; Onn A; Peled N
    Eur Respir J; 2014 Jul; 44(1):217-38. PubMed ID: 24525442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are we on the verge of lung-cancer screening in the Netherlands?].
    Smit AA; Moons-Pasic A; Bresser P
    Ned Tijdschr Geneeskd; 2015; 159():A8933. PubMed ID: 26058769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus statement on a screening programme for the detection of early lung cancer in Poland.
    Rzyman W; Didkowska J; Dziedzic R; Grodzki T; Orłowski T; Szurowska E; Langfort R; Biernat W; Kowalski D; Dyszkiewicz W; Jędrzejczyk T; Zdrojewski T; Nawrocki S; Jassem E; Adamek M
    Adv Respir Med; 2018; 86(1):53-74. PubMed ID: 29490422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer screening has the potential to safe lives, but shall we do it?
    Russi E
    Swiss Med Wkly; 2011; 141():w13185. PubMed ID: 21491209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?].
    Lanthier L; Bouchard N; Huard G; Plourde ME; Cauchon M
    Rev Med Interne; 2020 May; 41(5):350-351. PubMed ID: 32312589
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantification of growth patterns of screen-detected lung cancers: The NELSON study.
    Heuvelmans MA; Vliegenthart R; de Koning HJ; Groen HJM; van Putten MJAM; Yousaf-Khan U; Weenink C; Nackaerts K; de Jong PA; Oudkerk M
    Lung Cancer; 2017 Jun; 108():48-54. PubMed ID: 28625647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
    Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
    BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
    Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
    Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial.
    Iaccarino JM; Steiling KA; Wiener RS
    Ann Am Thorac Soc; 2018 Dec; 15(12):1493-1495. PubMed ID: 30199643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.